The cell game: Sam Waksal’s fast money and false promises – and the fate of ImClone’s cancer drug
J. Clin. Invest. Carlos L. Arteaga, et al. 114:743
doi:10.1172/JCI22931 [Go to this article.]

Problems with a PDF?